Erectile Dysfunction (ED)
Summary
Erectile Dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. ED can be psychogenic (Sudden onset, Situational, Morning erections preserved) or organic (Gradual onset, Progressive, Vascular, Neurogenic, Hormonal, Drug-induced). The most common cause is vascular disease, making ED a "Canary in the Coalmine" – It often precedes symptomatic coronary artery disease by 3-5 years (Penile arteries are smaller than coronary arteries and affected earlier). Assessment includes cardiovascular risk evaluation, hormonal screening (Testosterone), and psychological assessment. Management involves lifestyle modification (Smoking cessation, Weight loss, Exercise), treatment of underlying conditions, and PDE-5 Inhibitors (Sildenafil, Tadalafil) as first-line pharmacotherapy. PDE-5 Inhibitors are contraindicated with Nitrates (Risk of severe hypotension).
Key Facts
- Definition: Inability to achieve/maintain erection sufficient for sex.
- Prevalence: ~40% of men aged 40; ~70% aged 70.
- Psychogenic vs Organic: Sudden vs Gradual onset. Morning erections present vs absent.
- "Canary in the Coalmine": ED predates MI/Stroke by 3-5 years.
- First-Line Treatment: PDE-5 Inhibitors (Sildenafil, Tadalafil).
- Contraindication: Nitrates + PDE-5 Inhibitors = Severe Hypotension.
Clinical Pearls
"ED Before MI": Erectile dysfunction is often the first sign of systemic vascular disease. Consider CV risk assessment.
"Morning Erections = Psychogenic": If morning/nocturnal erections are preserved, the cause is likely psychogenic.
"Nitrates + Sildenafil = Hypotension": NEVER co-prescribe. 24-48 hour washout required.
"Check Testosterone in ED": Low testosterone is common and treatable.
Why This Matters Clinically
ED is extremely common and often under-reported. It is an important marker for cardiovascular disease and significantly impacts quality of life.
Prevalence
- ~40% of men aged 40.
- ~70% of men aged 70.
- Prevalence increases with age.
Risk Factors
| Factor | Notes |
|---|---|
| Cardiovascular Disease | Atherosclerosis. Hypertension. |
| Diabetes Mellitus | Vascular + Neurogenic. |
| Smoking | |
| Obesity | |
| Hyperlipidaemia | |
| Sedentary Lifestyle | |
| Hypertension | |
| Depression / Anxiety | |
| Medications | Antihypertensives (Thiazides, Beta-Blockers), Antidepressants (SSRIs), Antiandrogens. |
| Alcohol / Substance Abuse | |
| Pelvic Surgery / Radiotherapy | Prostatectomy. Colorectal surgery. |
| Neurological Disease | MS. Spinal cord injury. |
| Hypogonadism | Low Testosterone. |
Psychogenic ED
| Feature | Notes |
|---|---|
| Onset | Sudden. |
| Situational | With certain partners/situations. |
| Morning Erections | Preserved. |
| Causes | Performance anxiety. Depression. Relationship issues. Stress. |
Organic ED
| Feature | Notes |
|---|---|
| Onset | Gradual. Progressive. |
| Non-Situational | Consistent. |
| Morning Erections | Absent or reduced. |
| Causes | Vascular. Neurogenic. Hormonal. Drug-induced. |
Causes of Organic ED
| Type | Examples |
|---|---|
| Vascular (Most Common) | Atherosclerosis. Diabetes. Hypertension. Smoking. |
| Neurogenic | Diabetes. MS. Parkinson's. Spinal cord injury. Pelvic surgery (Nerve damage). |
| Hormonal | Hypogonadism (Low Testosterone). Hyperprolactinaemia. Thyroid disorders. |
| Drug-Induced | Antihypertensives (Thiazides, Beta-blockers). Antidepressants (SSRIs). Antiandrogens. |
| Structural | Peyronie's Disease. |
| Post-Surgical | Radical Prostatectomy. Colorectal surgery. |
Erection Mechanism
| Step | Detail |
|---|---|
| Sexual Stimulation | Parasympathetic (S2-S4). |
| Nitric Oxide (NO) Release | From nerves and endothelium. |
| Smooth Muscle Relaxation | Corpora Cavernosa. |
| Arterial Inflow Increases | Helicine arteries dilate. |
| Veno-Occlusive Mechanism | Sinusoids compress veins. Blood trapped. |
| Erection |
Detumescence
- Noradrenaline -> Smooth muscle contraction -> Venous outflow -> Detumescence.
PDE-5 Role
- Phosphodiesterase Type 5 (PDE-5) breaks down cGMP (Which causes smooth muscle relaxation).
- PDE-5 Inhibitors (Sildenafil, Tadalafil) prevent cGMP breakdown -> Prolonged erection.
History
| Question | Purpose |
|---|---|
| Onset | Sudden (Psychogenic) vs Gradual (Organic). |
| Morning Erections | Preserved = Psychogenic. |
| Relationship Issues | |
| Libido | Low = Hypogonadism. |
| Symptoms of Hypogonadism | Fatigue. Low mood. Reduced body hair. |
| Medications | Drug-induced causes. |
| Cardiovascular Symptoms | Chest pain. SOB. Claudication. |
| Diabetes / Hypertension | |
| Surgical History | Pelvic surgery. |
| Psychological | Depression. Anxiety. Stress. |
| Smoking / Alcohol |
Examination
| Finding | Notes |
|---|---|
| BMI / Waist Circumference | Obesity. Metabolic syndrome. |
| Blood Pressure | Hypertension. |
| Cardiac Examination | |
| Peripheral Pulses | Vascular disease. |
| Genitalia | Peyronie's plaques. Testicular size (Atrophy = Hypogonadism). |
| Secondary Sexual Characteristics | Reduced body hair (Hypogonadism). |
| Prostate (DRE) | If indicated. |
Blood Tests
| Test | Purpose |
|---|---|
| Fasting Glucose / HbA1c | Diabetes. |
| Lipid Profile | Cardiovascular risk. |
| Testosterone (Morning Sample) | Hypogonadism. |
| LH, FSH, Prolactin | If low Testosterone (Primary vs Secondary). |
| TFTs | Thyroid disorders. |
| PSA | If considering Testosterone replacement. |
Cardiovascular Assessment
- Calculate CV risk (QRISK).
- Consider ECG, Exercise tolerance test if symptoms or high risk.
Specialist Tests (If Indicated)
| Test | Purpose |
|---|---|
| Nocturnal Penile Tumescence (NPT) | Differentiates Psychogenic vs Organic. |
| Doppler Ultrasound (Penile) | Assess vascular inflow. |
| Intracavernosal Injection Test | Response to Alprostadil. |
Principles
- Treat Underlying Cause (Diabetes, Hypertension, Hypogonadism).
- Lifestyle Modification.
- Pharmacotherapy (PDE-5 Inhibitors First-Line).
- Psychological Support If indicated.
- Second-Line Therapies If PDE-5 Inhibitors fail.
Lifestyle Modification
| Intervention | Notes |
|---|---|
| Smoking Cessation | |
| Weight Loss | |
| Exercise | Improves vascular function. |
| Reduce Alcohol | |
| Address Psychological Factors | Relationship counselling. CBT. |
First-Line: PDE-5 Inhibitors
| Drug | Dose | Onset | Duration | Notes |
|---|---|---|---|---|
| Sildenafil (Viagra) | 25-100mg. | 30-60 min. | 4-5 hours. | Take on empty stomach. |
| Tadalafil (Cialis) | 10-20mg (PRN) OR 2.5-5mg (Daily). | 30 min. | 36 hours ("Weekend Pill"). | Can take with food. Daily dosing available. |
| Vardenafil (Levitra) | 5-20mg. | 30-60 min. | 4-5 hours. | |
| Avanafil (Spedra) | 50-200mg. | 15-30 min. | 6 hours. | Fastest onset. |
Contraindications to PDE-5 Inhibitors:
| Contraindication | Notes |
|---|---|
| Nitrates | ABSOLUTE. Severe hypotension. 24-48hr washout. |
| Severe Cardiovascular Disease | Unstable angina. Recent MI/Stroke. Uncontrolled HTN. Severe heart failure. |
| Hypotension | |
| Hepatic Impairment (Severe) |
Second-Line Therapies
| Therapy | Notes |
|---|---|
| Vacuum Erection Device (VED) | Mechanical. Non-invasive. |
| Intracavernosal Injection (Alprostadil / Caverject) | Self-injection. Effective. Risk of priapism. |
| Intraurethral Alprostadil (MUSE) | Pellet. Less invasive than injection. |
| Testosterone Replacement | If hypogonadism confirmed. |
Third-Line
| Therapy | Notes |
|---|---|
| Penile Prosthesis (Implant) | Surgical. Last resort. Very effective. |
ED as a Cardiovascular Marker
- ED often precedes coronary artery disease by 3-5 years.
- Artery size hypothesis: Penile arteries (1-2mm) affected before coronary arteries (3-4mm).
CV Risk Stratification (Princeton Consensus)
| Risk | Examples | Action |
|---|---|---|
| Low Risk | Mild stable angina. Controlled hypertension. | Safe for sexual activity. PDE-5 safe. |
| Intermediate Risk | Recent MI (<6 weeks). Moderate heart failure (NYHA II). | Further CV assessment before PDE-5. |
| High Risk | Unstable angina. Severe heart failure (NYHA III-IV). Uncontrolled hypertension. | Stabilise before sexual activity/PDE-5. |
Key Guidelines
| Guideline | Organisation | Notes |
|---|---|---|
| EAU Guidelines (Male Sexual Dysfunction) | European Association of Urology | Comprehensive. |
| AUA Guideline | American Urological Association | |
| BSSM Guidelines | British Society for Sexual Medicine | UK guidance. |
Scenario 1:
- Stem: A 55-year-old diabetic man presents with gradual onset ED and absent morning erections. What is the likely cause and first-line treatment?
- Answer: Organic ED (Likely vascular/neurogenic from Diabetes). First-line: PDE-5 Inhibitor (e.g., Sildenafil or Tadalafil).
Scenario 2:
- Stem: A man on Sildenafil for ED develops chest pain. Why is GTN contraindicated?
- Answer: PDE-5 Inhibitors + Nitrates = Severe Hypotension. Risk of CV collapse.
Scenario 3:
- Stem: What screening should be done in a 50-year-old presenting with new ED?
- Answer: Cardiovascular risk assessment (QRISK, Lipids, Glucose, BP) and Testosterone level.
What is Erectile Dysfunction?
ED is when a man cannot get or keep an erection firm enough for sex. It is very common and becomes more frequent with age.
What causes it?
- Physical causes: Poor blood flow (Diabetes, Heart disease, Smoking), Nerve damage, Hormone problems.
- Psychological causes: Stress, Anxiety, Depression, Relationship issues.
How is it treated?
- Lifestyle changes: Stop smoking, Lose weight, Exercise.
- Tablets: Sildenafil (Viagra), Tadalafil (Cialis) – Increase blood flow.
- Other treatments: Injections, Vacuum devices, Implants (Rare).
Key Counselling Points
- It's Common: "ED is very common – you are not alone."
- Check Your Heart: "ED can be an early sign of heart disease – Get your heart checked."
- Don't Take with Nitrates: "If you take GTN spray for angina, you MUST NOT take Sildenafil."
| Standard | Target |
|---|---|
| CV risk assessment in men with ED | 100% |
| Testosterone checked in ED | >0% |
| PDE-5 inhibitor counselled on Nitrate contraindication | 100% |
- EAU Guidelines. Male Sexual Dysfunction. uroweb.org
- BSSM Guidelines. Management of ED. bssm.org.uk
Last Reviewed: 2025-12-24 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. If you have concerns about ED, please consult a healthcare professional.